Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Rein Therapeutics Inc.
Swot
Rein Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Rein Therapeutics Inc. has 8 Strengths, 17 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(17)
Opportunity
(6)
Threats
(0)
Others
(0)
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Stock with Low PE (PE < = 10)
Volume Shockers
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Biggest Price Losers from Open
High Volume, Top Losers
High volume, top losers
Top Losers
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
